MBIO - Mustang Bio, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.65 -0.05 (-3.03%)	---	---	0.0 (0.0%)	0.02 (0.91%)	-0.02 (-1.2%)	-0.04 (-2.44%)	-0.04 (-2.44%)

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.19
Diluted EPS:: -0.19
Basic P/E:: -8.4211
Diluted P/E:: -8.4211
RSI(14) 1m:: 0.0
VWAP:: 1.6
RVol:: 0.9177

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.68 +0.02 (+1.2%)	Oct 15 15:09
1m	Price increase 1m	1.66 +0.02 (+1.41%)	Oct 15 14:52
1m	Price decrease 1m	1.61 -0.02 (-1.23%)	Oct 15 14:01
1m	Price decrease 1m	1.63 -0.03 (-1.81%)	Oct 15 11:03
1m	Price increase 1m	1.66 +0.02 (+1.22%)	Oct 15 11:02